Sign inGet started

Waldman Reid Alexander

Insider CIK 2107415 · MANE Chief Executive Officer, Director · ACHV Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
MANE Veradermics, Inc M Exercise deriv2026-08-172026-08-183,452— $00SEC↗
MANE Veradermics, Inc S Sale2026-08-172026-08-18249$111.28 $27.7K170,824SEC↗
MANE Veradermics, Inc S Sale2026-08-172026-08-183,000$109.38 $328.1K171,073SEC↗
MANE Veradermics, Inc S Sale2026-08-172026-08-1827,490$108.45 $2.98M174,073SEC↗
MANE Veradermics, Inc S Sale2026-08-172026-08-1825,234$107.53 $2.71M201,563SEC↗
MANE Veradermics, Inc S Sale2026-08-172026-08-1811,527$106.72 $1.23M226,797SEC↗
MANE Veradermics, Inc M Exercise2026-08-172026-08-183,452$12.19 $42.1K238,324SEC↗
MANE Veradermics, Inc M Exercise deriv2026-08-172026-08-183,452— $00SEC↗
MANE Veradermics, Inc S Sale2026-08-172026-08-18249$111.28 $27.7K170,824SEC↗
MANE Veradermics, Inc S Sale2026-08-172026-08-183,000$109.38 $328.1K171,073SEC↗
MANE Veradermics, Inc S Sale2026-08-172026-08-1827,490$108.45 $2.98M174,073SEC↗
MANE Veradermics, Inc S Sale2026-08-172026-08-1825,234$107.53 $2.71M201,563SEC↗
MANE Veradermics, Inc S Sale2026-08-172026-08-1811,527$106.72 $1.23M226,797SEC↗
MANE Veradermics, Inc M Exercise2026-08-172026-08-183,452$12.19 $42.1K238,324SEC↗
ACHV ACHIEVE LIFE SCIENCES, INC A Award deriv2026-07-272026-07-2916,700— $016,700SEC↗
ACHV ACHIEVE LIFE SCIENCES, INC A Award deriv2026-07-272026-07-2925,000— $025,000SEC↗
ACHV ACHIEVE LIFE SCIENCES, INC A Award deriv2026-07-272026-07-2916,700— $016,700SEC↗
ACHV ACHIEVE LIFE SCIENCES, INC A Award deriv2026-07-272026-07-2925,000— $025,000SEC↗
ACHV ACHIEVE LIFE SCIENCES, INC A Award deriv2026-05-292026-06-0247,250— $047,250SEC↗
MANE Veradermics, Inc C Conversion deriv2026-02-052026-02-051,437— $00SEC↗
MANE Veradermics, Inc C Conversion2026-02-052026-02-051,437— $0234,872SEC↗
MANE Veradermics, Inc A Award deriv2026-02-032026-02-05556,399— $0556,399SEC↗